What is STKL's health score?

SunOpta Inc. (STKL) has a TradeApes health score of 48 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is STKL's estimated fair value?

Based on our 5-year discounted cash flow model, SunOpta Inc.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is STKL undervalued or overvalued?

Our model currently rates STKL as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

1 free score card remaining

SunOpta Inc. (STKL)

Consumer Defensive Inconclusive inconclusive mixed

$6.5

Updated: 2026-07-16

TradeApes Score

Financial Strength

35 Weak

Operating Trend

20 Stressed

Relative Value

95 Strong

Capital Allocation

35 Weak

Risk Management

50 Mixed

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− Sharp revenue decline — sales down more than 15% year over year

Unlock Full Report →

Industry Related Stocks

AMBEV S.A. (ABEV) Accredited Solutions, Inc. (ASII) Blue Line Holdings, Inc. (BLNH) BRC Inc. (BRCC) BUDA JUICE, INC. (BUDA) COCA-COLA EUROPACIFIC PARTNERS plc (CCEP)

See all Consumer Defensive stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.